focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

Thu, 24th Oct 2019 10:31

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.

----------

FTSE 100 - WINNERS

----------

RELX, up 3.4%. The business publisher and analytics firm reaffirmed 2019 guidance after a solid first nine months of the year. RELX delivered 4% underlying revenue growth for the first nine months of 2019, with all four business areas delivering an improvement year-on-year. "The full-year outlook is unchanged. As we enter the final quarter of 2019 key business trends are in line with the full year 2018. We remain confident that, by continuing to execute on our strategy, we will deliver another year of underlying growth in revenue and in adjusted operating profit, together with growth in adjusted earnings per share on a constant currency basis in 2019," said RELX.

----------

AstraZeneca, up 3.2%. The pharma giant posted a dip in third-quarter profit as a result of research & development expenses, but did upgrade annual sales guidance. For the three months ended September, pretax profit was USD409 million, down 14%. This reduction was the result of a 32% rise in selling, general & administrative costs, on top of a 5.5% jump in research & development expense. Total revenue rose 20%, reaching USD6.41 billion thanks both to a 16% rise in product sales and to a more than trebling of collaboration revenue. Astra has upgraded product sales guidance for 2019 and is now expecting a low to mid-teens percentage rise, having previously expected a low double-digit percentage increase. Astra also reiterated guidance for core earnings per share of between USD3.50 and USD3.70 for 2019 as a whole.

----------

AVEVA Group, up 2.2%. The engineering and industrial software firm said strong sales execution has led to solid revenue growth. AVEVA achieved low double-digit revenue growth on a proforma constant-currency basis in the financial first half ended September. On a reported basis, revenue benefited from foreign exchange movements, the company said. The revenue mix was "positive", said AVEVA, with every region delivering growth. Rental & Subscription was "very strong", partly offset by expected lower revenue in the Initial & Perpetual Licences and Services units.

----------

FTSE 100 - LOSERS

----------

Royal Bank of Scotland, down 2.2%. In the three months to September 30, RBS recorded an operating pretax loss of GBP8 million compared to a GBP961 million profit a year before. The loss was attributed to a GBP900 million PPI provision. The bank's loss attributable to shareholders totalled GBP315 million, compared to a GBP448 million profit in the third quarter last year and a GBP1.33 billion profit in the second quarter of this year. Net interest income declined 6.5% to GBP2.01 billion from GBP2.15 billion. RBS said its group was hurt from a "particularly challenging" quarter from investment bank NatWest Markets.

----------

FTSE 250 - WINNERS

----------

KAZ Minerals, up 6.2%. The miner expects to beat gold guidance for 2019 after a "record" third quarter of the year. KAZ has previously guided for 2019 gold production between 170,000 ounces and 185,000 ounces. However, it now expects to beat the top end of that range by 5%. This comes after third-quarter gold production of 58,500 ounces for the three months to September, 32% higher than the quarter before. Copper production was 82,900 tonnes, 6.8% higher than the prior three months. KAZ said the rises in production came after strong performances from the Aktogay mine in eastern Kazakhstan and the Bozshakol mine in the north of the country.

----------

FTSE 250 - LOSERS

----------

RHI Magnesita, down 4.4%. The refractory products firm warned a continued deterioration in steel-sector sales volumes are hurting earnings. As a result, RHI Magnesita is predicting 2019 adjusted earnings before interest, tax, and amortisation to be between EUR400 million and EUR410 million, down from the EUR428.1 million recorded in 2018. The Vienna, Austria-headquartered company said Steel revenue for the three months to September 30 has fallen 14% year-on-year and a materially lower contribution from the Steel unit in the second half against the first half is now expected. The global steel market has weakened further and, as a result, customers have significantly reduced their refractory products inventories, RHI Magnesita explained.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Woodford Patient Capital Trust, up 30%. The firm has appointed Schroder Investment Management as its new portfolio manager, following the exit of star fund manager Neil Woodford last week. Schroder Investment Management, part of FTSE 100 listed asset manager Schroders, will take over as portfolio manager by the end of 2019, when the trust will be renamed Schroder UK Public Private Trust.

----------

Petro Matad, up 76%. The Mongolian oil explorer reported positive results from testing of the Heron-1 well. A first test was performed over a three metre zone at 2,872 metres and indicated an oil column height of at least 70 metres in the Heron-1 well. The second drill stem test was performed over a 12 metre interval from 2,834 metres, with oil and some associated gas flowing to surface without the need for any artificial lift. The peak production recorded during the test was 821 barrels of oil per day and, for the main flow period, the well flowed at an average rate of 200 barrels a day. The company said the Heron-1 flow rate was very encouraging and could indicate a "too conservative" recovery estimate for the Heron structure, however more wells would be required to prove the total volumes in the structure.

----------

Motif Bio, up 23%. The biopharmaceutical firm is to team up with a US Army-funded research institute to evaluate the use of iclaprim in administering antibiotics.

----------

Eurasia Mining, up 32%. The firm said two of the largest investment banks in Russia and China have expressed interest in the company's assets, with talks over their future ongoing.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

C4X Discovery, down 57%. The firm is to raise GBP5.5 million by placing shares at 15 pence each, and also offer 1 share per 9 existing in an open offer to raise a further GBP1.0 million. C4X will use the funds to strengthen the balance sheet and expands the portfolio.

----------

Mobile Streams, down 31%. The firm continues to seek a new nominated advisor, but will not make the October 28 deadline when shares will be suspended if it has not done so. After that, it has a month to get a new nomad, or it will be removed from the London Stock Exchange.

----------

Distil, down 20%. The alcoholic drinks maker swung to a loss in the first half with the company citing tough conditions in the UK unflavoured gin market. The company, which owns the RedLeg rum brand, Blackwood's gin and Blavod vodka, swung to a first half pretax loss of GBP1,000 in the six months to September 30. Last year, it made a GBP101,000 pretax profit. Revenue fell by 29% year-on-year to GBP824,000 from GBP1.2 million. For the full-year Distil expects revenue to lag behind market forecasts, though the company expects operating profit to be in line due to cost control measures.

----------

By George Collard; georgecollard@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
20 Jun 2023 10:52

C4X Discovery chair steps down; Clive Dix named interim chair & CEO

(Alliance News) - C4X Discovery Holdings PLC said on Tuesday that Chair Eva-Lotta Allan will step down with immediate effect, and that Clive Dix will become interim executive chair & chief executive officer until a replacement is found.

Read more
1 Jun 2023 17:32

C4X says MALT-1 study shows no UGT1A1 liability seen in competitors

(Alliance News) - C4X Discovery Holdings PLC on Thursday said it has completed its preclinical study showing that its MALT-1 lead compounds are free of UGT1A1 enzyme liability at clinically meaningful doses, unlike competitor chemistries.

Read more
26 Apr 2023 17:58

EARNINGS SUMMARY: Bluebird swings to loss, RBG profit rises strongly

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
19 Apr 2023 15:42

UK earnings, trading statements calendar - next 7 days

Thursday 20 April 
AJ Bell PLCTrading Statement
Arix Bioscience PLCFull Year Results
Centamin PLCTrading Statement
Deliveroo PLCTrading Statement
Dianomi PLCFull Year Results
Dunelm Group PLCQ3 Results
Foxtons Group PLCTrading Statement
GB Group PLCTrading Statement
Hochschild Mining PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
PensionBee Group PLCTrading Statement
Rentokil Initial PLCTrading Statement
Rio Tinto PLCTrading Statement
Senior PLCTrading Statement
Segro PLCTrading Statement
WH Smith PLCHalf Year Results
Friday 21 April 
Angle PLCFull Year Results
BHP Group LtdTrading Statement
Lookers PLCFull Year Results
Monday 24 April 
Brighton Pier Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Checkit PLCFull Year Results
Egdon Resources PLCHalf Year Results
Keystone Law Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Novacyt SAFull Year Results
Tuesday 25 April 
AB Dynamics PLCHalf Year Results
Anglo American PLCTrading Statement
Associated British Foods PLCHalf Year Results
Avacta Group PLCFull Year Results
Banco Santander SAQ1 Results
Card Factory PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Corero Network Security PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
hVIVO PLCFull Year Results
IWG PLCTrading Statement
Jadestone Energy PLCFull Year Results
Next Fifteen Communications Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Petrofac LtdFull Year Results
Quilter PLCTrading Statement
Resolute Mining LtdTrading Statement
RWS Holdings PLCTrading Statement
Travis Perkins PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
Whitbread PLCFull Year Results
Wednesday 26 April 
1Spatial PLCFull Year Results
Biome Technologies PLCFull Year Results
Bunzl PLCQ1 Results
C4X Discovery Holdings PLCHalf Year Results
CRH PLCTrading Statement
Ecora Resources PLCTrading Statement
Frenkel Topping Group PLCFull Year Results
Fresnillo PLCTrading Statement
Glencore PLCTrading Statement
GSK PLCQ1 Results
Home REIT PLCHalf Year Results
Learning Technologies Group PLCFull Year Results
Man Group PLCTrading Statement
RBG Holdings PLCFull Year Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Smith & Nephew PLCTrading Statement
Standard Chartered PLCQ1 Results
Trifast PLCTrading Statement
Warpaint London PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
22 Feb 2023 13:41

C4X Discovery launches medicine platform on Parkinson's study results

(Alliance News) - C4X Discovery Holdings PLC on Wednesday launched PatientSeek, a precision medicine platform for patient stratification based on genetic subgroups.

Read more
22 Feb 2023 12:43

C4X Discovery launches new precision medicine platform

(Sharecast News) - C4X Discovery launched a new precision medicine platform called 'PatientSeek' on Wednesday, after a successful research collaboration with the Garvan Institute of Medical Research.

Read more
19 Jan 2023 16:54

TRADING UPDATES: Mode Global considers sale; RPS takeover complete

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
19 Jan 2023 16:14

C4X makes positive progress with potential cancer programme

(Sharecast News) - C4X Discovery updated on its 'MALT-1' inhibitor programme on Thursday, explaining that the overexpression or over-activation of MALT-1 has been observed in a range of lymphomas and leukemias such as MALT lymphoma, diffuse large B-cell lymphoma and chronic lymphocytic leukaemia.

Read more
17 Jan 2023 15:55

UK shareholder meetings calendar - next 7 days

Wednesday 18 January 
Diploma PLCAGM
GCM Resources PLCAGM
John Lewis of Hungerford PLCAGM
Tlou Energy LtdGM re share placing
Topps Tiles PLCAGM
Tracsis PLCAGM
WH Smith PLCAGM
Thursday 19 January 
Cardiff Property PLCAGM 
Equipmake Holdings PLCAGM
J Smart & Co (Contractors) PLCAGM
Pioneer Media Holdings IncAGM
Scotgold Resources LtdAGM
Friday 20 January 
Appreciate Group PLCGM re acquisition by PayPal Holdings Inc and Court Meeting 
Character Group PLCAGM
Monday 23 January 
Midatech Pharma PLCGM re proposed acquisition of Bioasis Technologies Inc
Tuesday 24 January 
C4X Discovery Holdings PLCAGM
Smiths News PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
10 Jan 2023 15:38

C4X promotes Nick Ray to chief scientific officer

(Sharecast News) - Drug discovery company C4X announced the appointment of Nick Ray as its chief scientific officer on Tuesday, with immediate effect.

Read more
10 Jan 2023 15:10

C4X Discovery promotes Nick Ray to chief scientific officer

(Alliance News) - C4X Discovery Holdings PLC on Tuesday said it appointed a new scientific officer, promoting internally.

Read more
15 Dec 2022 12:13

C4X Holdings loss widens; outlook strong amid AstraZeneca partnership

(Alliance News) - C4X Discovery Holdings PLC on Thursday said its annual loss widened, but it remains positive in its outlook, citing a partner programme with AstraZeneca PLC.

Read more
8 Dec 2022 15:46

UK earnings, trading statements calendar - next 7 days

Friday 9 December 
Anglo American PLCTrading Statement
Associated British Foods PLCTrading Statement
Berkeley Group Holdings PLCHalf Year Results
Diploma PLCFull Year Results
Taylor Maritime Investments LtdHalf Year Results
Monday 12 December 
Coral Products PLCHalf Year Results
Tuesday 13 December 
Begbies Traynor Group PLCHalf Year Results
Chemring Group PLCFull Year Results
FRP Advisory Group PLCHalf Year Results
Global Ports Holding PLCHalf Year Results
Hyve Group PLCFull Year Results
Ocado Group PLCTrading Statement
RWS Holdings PLCFull Year Results
Sosandar PLCHalf Year Results
Zytronic PLCFull Year Results
Wednesday 14 December 
Cohort PLCHalf Year Results
CyanConnode Holdings PLCHalf Year Results
Foresight Sustainable Forestry Co PLCFull Year Results
IntegraFin Holdings PLCFull Year Results
SThree PLCTrading Statement
Tui AGFull Year Results
Watches of Switzerland Group PLCHalf Year Results
Thursday 15 December 
Biffa PLCHalf Year Results
C4X Discovery Holdings PLCFull Year Results
Currys PLCHalf Year Results
Libertine Holdings PLCHalf Year Results
RWS Holdings PLCFull Year Results
Serco Group PLCTrading Statement
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
28 Nov 2022 14:02

C4X Discovery signs up-to-$402m deal with AstraZeneca

(Sharecast News) - Drug discovery specialist C4X has signed an exclusive worldwide licensing agreement with AstraZeneca worth up to $402m, it announced on Monday, for its 'NRF2 Activator' programme.

Read more
28 Nov 2022 12:07

LONDON MARKET MIDDAY: Global equities shaken by civil unrest in China

(Alliance News) - Stock prices in London were in the red on Monday, as protests across China against its strict Covid policies undermined global risk appetite.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.